MCQOPTIONS
 Saved Bookmarks
				| 1. | 
                                    Concerning the prophylactic use of G-CSF during cancer chemotherapy: | 
                            
| A. | it decreases the duration of neutropenia | 
| B. | it decreases the severity of the neutropenic nadir | 
| C. | it increases platelet numbers | 
| D. | it potentiates the effect of chemotherapy | 
| E. | it is only useful in established neutropenia | 
| Answer» C. it increases platelet numbers | |